Answer
The most common adverse reactions in adults receiving mirabegron 50 mg for overactive bladder in three 12-week phase 3 double-blind, placebo-controlled trials were tachycardia (1.2%) and urinary tract infections (2.9%).
Sources for this answer
- Mirabegron Astellas 25mg & 50mg prolonged-release tabletsAstellas Pharma Ltd · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked